The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

The U.S. Food and Drug Administration on Thursday publicly shared over 200 archived so-called complete response letters related to medicines that were later approved, in a bid to improve transparency ...

The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...

The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...